172 related articles for article (PubMed ID: 38347613)
1. Novel quinazolines bearing 1,3,4-thiadiazole-aryl urea derivative as anticancer agents: design, synthesis, molecular docking, DFT and bioactivity evaluations.
Masoudinia S; Samadizadeh M; Safavi M; Bijanzadeh HR; Foroumadi A
BMC Chem; 2024 Feb; 18(1):30. PubMed ID: 38347613
[TBL] [Abstract][Full Text] [Related]
2. Design, Synthesis, and Biological Evaluation of 1,2,4-Thiadiazole-1,2,4-Triazole Derivatives Bearing Amide Functionality as Anticancer Agents.
Pragathi YJ; Sreenivasulu R; Veronica D; Raju RR
Arab J Sci Eng; 2021; 46(1):225-232. PubMed ID: 32837812
[TBL] [Abstract][Full Text] [Related]
3. Novel Thioether-Bridged 2,6-Disubstituted and 2,5,6-Trisubstituted Imidazothiadiazole Analogues: Synthesis, Antiproliferative Activity, ADME, and Molecular Docking Studies.
Ozcan I; Akkoc S; Alici H; Capanlar S; Sahin O; Tahtaci H
Chem Biodivers; 2023 Jan; 20(1):e202200884. PubMed ID: 36445849
[TBL] [Abstract][Full Text] [Related]
4. Chemical Characterization,
Ansari JA; Ahmad MK; Fatima N; Azad I; Mahdi AA; Satyanarayan GNV; Ahmad N
Anticancer Agents Med Chem; 2022; 22(20):3416-3437. PubMed ID: 35125087
[TBL] [Abstract][Full Text] [Related]
5. Novel 1,3-diaryl pyrazole derivatives bearing methylsulfonyl moiety: Design, synthesis, molecular docking and dynamics, with dual activities as anti-inflammatory and anticancer agents through selectively targeting COX-2.
Shaker AMM; Shahin MI; AboulMagd AM; Abdel Aleem SA; Abdel-Rahman HM; Abou El Ella DA
Bioorg Chem; 2022 Dec; 129():106143. PubMed ID: 36191430
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, molecular modeling, DFT, ADME and biological evaluation studies of some new 1,3,4-oxadiazole linked benzimidazoles as anticancer agents and aromatase inhibitors.
Acar Çevik U; Celik I; Işık A; Ahmad I; Patel H; Özkay Y; Kaplancıklı ZA
J Biomol Struct Dyn; 2023 Mar; 41(5):1944-1958. PubMed ID: 35037830
[TBL] [Abstract][Full Text] [Related]
7. Hydrazide-hydrazones as Small Molecule Tropomyosin Receptor Kina se A (TRKA) Inhibitors: Synthesis, Anticancer Activities,
Alam MS; Lee DU
Med Chem; 2022; 19(1):47-63. PubMed ID: 35490310
[TBL] [Abstract][Full Text] [Related]
8. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F
Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967
[TBL] [Abstract][Full Text] [Related]
9. Microwave-Assisted Facile Synthesis, Anticancer Evaluation and Docking Study of N-((5-(Substituted methylene amino)-1,3,4-thiadiazol-2-yl)methyl) Benzamide Derivatives.
Tiwari SV; Siddiqui S; Seijas JA; Vazquez-Tato MP; Sarkate AP; Lokwani DK; Nikalje APG
Molecules; 2017 Jun; 22(6):. PubMed ID: 28617341
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, computational study and cytotoxic evaluation of some new quinazoline derivatives containing pyrimidine moiety.
Zare S; Emami L; Faghih Z; Zargari F; Faghih Z; Khabnadideh S
Sci Rep; 2023 Sep; 13(1):14461. PubMed ID: 37660139
[TBL] [Abstract][Full Text] [Related]
11. Discovery of new anticancer thiourea-azetidine hybrids: design, synthesis, in vitro antiproliferative, SAR, in silico molecular docking against VEGFR-2, ADMET, toxicity, and DFT studies.
Parmar DR; Soni JY; Guduru R; Rayani RH; Kusurkar RV; Vala AG; Talukdar SN; Eissa IH; Metwaly AM; Khalil A; Zunjar V; Battula S
Bioorg Chem; 2021 Oct; 115():105206. PubMed ID: 34339975
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of novel 1,3,4-thiadiazole derivatives as possible anticancer agents.
Çevik UA; Osmaniye D; Levent S; Sağlik BN; Çavuşoğlu BK; Karaduman AB; Özkay Y; Kaplancikli ZA
Acta Pharm; 2020 Dec; 70(4):499-513. PubMed ID: 32412436
[TBL] [Abstract][Full Text] [Related]
13. Novel Hydrazone Derivatives of 3-Bromopyruvate: Synthesis, Evaluation of the Cytotoxic Effects, Molecular Docking and ADME Studies.
Beygi F; Mostoufi A; Mojaddami A
Chem Biodivers; 2022 Jun; 19(6):e202100754. PubMed ID: 35427437
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, Biological Evaluation and Molecular Docking Study of Cyclic Diarylheptanoids as Potential Anticancer Therapeutics.
Lu Y; Yin W; Alam MS; Kadi AA; Jahng Y; Kwon Y; Rahman AFMM
Anticancer Agents Med Chem; 2020; 20(4):464-475. PubMed ID: 31763968
[TBL] [Abstract][Full Text] [Related]
15. A New Series of Triazolothiadiazines as Potential Anticancer Agents for Targeted Therapy of Non-Small Cell Lung and Colorectal Cancers: Design, Synthesis, In silico and In vitro Studies Providing Mechanistic Insight into Their Anticancer Potencies.
Sever B; Altıntop MD; Çiftçi GA; Özdemir A
Med Chem; 2021; 17(10):1104-1128. PubMed ID: 33087032
[TBL] [Abstract][Full Text] [Related]
16. Design, Synthesis and Biological Evaluation of a Novel Series of Thiadiazole- Based Anticancer Agents as Potent Angiogenesis Inhibitors.
Altuğ-Tasa B; Kaya-Çavuşoğlu B; Koparal AT; Turan G; Koparal AS; Kaplancıklı ZA
Anticancer Agents Med Chem; 2021; 21(15):2041-2049. PubMed ID: 33390125
[TBL] [Abstract][Full Text] [Related]
17. Design, microwave assisted synthesis, and molecular modeling study of some new 1,3,4-thiadiazole derivatives as potent anticancer agents and potential VEGFR-2 inhibitors.
Atta-Allah SR; AboulMagd AM; Farag PS
Bioorg Chem; 2021 Jul; 112():104923. PubMed ID: 33932767
[TBL] [Abstract][Full Text] [Related]
18. Scaffold hopping and redesign approaches for quinazoline based urea derivatives as potent VEGFR-2 inhibitors.
Hadi SRAE; Lasheen DS; Soliman DH; Elrazaz EZ; Abouzid KAM
Bioorg Chem; 2020 Aug; 101():103961. PubMed ID: 32480170
[TBL] [Abstract][Full Text] [Related]
19. New N-(1,3,4-thiadiazol-2-yl)furan-2-carboxamide derivatives as potential inhibitors of the VEGFR-2.
Hekal MH; Farag PS; Hemdan MM; El-Sayed WM
Bioorg Chem; 2021 Oct; 115():105176. PubMed ID: 34303038
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, characterization, anticancer and
Alshammari MM; Soury R; Alenezi KM; Mushtque M; Rizvi MMA; Haque A
J Biomol Struct Dyn; 2022; 40(23):13075-13082. PubMed ID: 34551668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
